Skip to main content
Top
Published in: World Journal of Surgery 8/2021

01-08-2021 | Shock | Original Scientific Report

Does Liberal Prehospital and In-Hospital Tranexamic Acid Influence Outcome in Severely Injured Patients? A Prospective Cohort Study

Authors: Karlijn J. P. van Wessem, Luke P. H. Leenen

Published in: World Journal of Surgery | Issue 8/2021

Login to get access

Abstract

Background

Early hemorrhage control is important in trauma-related death prevention. Tranexamic acid (TXA) has shown to be beneficial in patients in hemorrhagic shock, although widespread adoption might result in incorrect TXA administration leading to increased morbidity and mortality.

Methods

A 7-year prospective cohort study with consecutive trauma patients admitted to a Level-1 Trauma Center ICU was performed to investigate administration of both pre- and in-hospital TXA and its relation to morbidity and mortality. Indication for prehospital and in-hospital TXA administration was (suspicion of) hemorrhagic shock, and/or systolic blood pressure (SBP) ≤ 90 mmHg. Demographics, data on physiology, resuscitation and outcomes were prospectively collected.

Results

Four hundred and twenty-two patients (71% males, median ISS 29, 95% blunt injuries) were included. Even though TXA patients were more severely injured with more deranged physiology, no differences in outcome were noted. Overall, thrombo-embolic complication rate was 8%. In half the patients, hemorrhagic shock was the indication for prehospital TXA, whereas 79% of in-hospital TXA was given based on suspicion of hemorrhagic shock. Thirteen percent of patients with SBP ≤ 90 mmHg in ED received no TXA at all. Based on SBP alone, 22% of prehospital TXA and 25% of in-hospital TXA were justified.

Conclusions

Despite being more severely injured, TXA patients had similar outcome compared to patients without TXA. Thrombo-embolic complication rate was low despite liberal use of both prehospital and in-hospital TXA. Caution should be exercised in selecting patients for TXA, although this might be challenging based on SBP alone in patients who do not yet show signs of deranged physiology on arrival in ED.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gruen RL, Jurkovich GJ, McIntyre LK et al (2006) Patterns of errors contributing to trauma mortality: lessons learned from 2,594 deaths. Ann Surg 244:371–380CrossRef Gruen RL, Jurkovich GJ, McIntyre LK et al (2006) Patterns of errors contributing to trauma mortality: lessons learned from 2,594 deaths. Ann Surg 244:371–380CrossRef
2.
go back to reference Evans JA, van Wessem KJ, McDougall D et al (2010) Epidemiology of traumatic deaths: comprehensive population-based assessment. World J Surg 34(1):158–163CrossRef Evans JA, van Wessem KJ, McDougall D et al (2010) Epidemiology of traumatic deaths: comprehensive population-based assessment. World J Surg 34(1):158–163CrossRef
5.
go back to reference CRASH-2 Trial Collaborators, Shakur H, Roberts I, Bautista R et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376(9734):23–32CrossRef CRASH-2 Trial Collaborators, Shakur H, Roberts I, Bautista R et al (2010) Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376(9734):23–32CrossRef
6.
go back to reference Valle EJ, Allen CJ, Van Haren RM et al (2014) Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg 76(6):1373–1378CrossRef Valle EJ, Allen CJ, Van Haren RM et al (2014) Do all trauma patients benefit from tranexamic acid? J Trauma Acute Care Surg 76(6):1373–1378CrossRef
7.
go back to reference Myers SP, Kutcher ME, Rosengart MR et al (2019) Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism. J Trauma Acute Care Surg 86(1):20–27CrossRef Myers SP, Kutcher ME, Rosengart MR et al (2019) Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism. J Trauma Acute Care Surg 86(1):20–27CrossRef
8.
go back to reference Richards JE, Fedeles BT, Chow JH et al (2021) Is Tranexamic acid associated with mortality or multiple organ failure following severe injury? Shock 55(1):55–60CrossRef Richards JE, Fedeles BT, Chow JH et al (2021) Is Tranexamic acid associated with mortality or multiple organ failure following severe injury? Shock 55(1):55–60CrossRef
10.
go back to reference Guyette FX, Brown JB, Zenati MS, STAAMP Study Group et al (2020) Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial. JAMA Surg 156(1):11–20. https://doi.org/10.1001/jamasurg.2020.4350 (Epub ahead of print. Erratum in: doi: 10.1001/jamasurg.2020.5809. PMID: 33016996; PMCID: PMC7536625)CrossRef Guyette FX, Brown JB, Zenati MS, STAAMP Study Group et al (2020) Tranexamic acid during prehospital transport in patients at risk for hemorrhage after injury: a double-blind, placebo-controlled, randomized clinical trial. JAMA Surg 156(1):11–20. https://​doi.​org/​10.​1001/​jamasurg.​2020.​4350 (Epub ahead of print. Erratum in: doi: 10.1001/jamasurg.2020.5809. PMID: 33016996; PMCID: PMC7536625)CrossRef
12.
go back to reference Rivas L, Estroff J, Sparks A et al (2021) The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study. Blood Coagul Fibrinolysis 32(1):37–43CrossRef Rivas L, Estroff J, Sparks A et al (2021) The incidence of venous thromboembolic events in trauma patients after tranexamic acid administration: an EAST multicenter study. Blood Coagul Fibrinolysis 32(1):37–43CrossRef
13.
go back to reference Cole E, Davenport R, Willett K et al (2015) Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study. Ann Surg 261(2):390–394CrossRef Cole E, Davenport R, Willett K et al (2015) Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study. Ann Surg 261(2):390–394CrossRef
14.
go back to reference Mitra B, Mazur S, Cameron PA, PATCH-Trauma Study Investigators et al (2014) Tranexamic acid for trauma: filling the “GAP” in evidence. Emerg Med Australas. 26(2):194–197CrossRef Mitra B, Mazur S, Cameron PA, PATCH-Trauma Study Investigators et al (2014) Tranexamic acid for trauma: filling the “GAP” in evidence. Emerg Med Australas. 26(2):194–197CrossRef
16.
go back to reference Gunning AC, Lansink KWW, van Wessem KJP et al (2015) Demographic patterns and outcomes of patients in level-1 trauma centers in three international trauma systems. World J Surg 39(11):2677–2684CrossRef Gunning AC, Lansink KWW, van Wessem KJP et al (2015) Demographic patterns and outcomes of patients in level-1 trauma centers in three international trauma systems. World J Surg 39(11):2677–2684CrossRef
17.
go back to reference Dewar DC, Tarrant SM, King KL et al (2013) Changes in the epidemiology and prediction of multiple-organ failure after injury. J Trauma Acute Care Surg 74(3):774–779CrossRef Dewar DC, Tarrant SM, King KL et al (2013) Changes in the epidemiology and prediction of multiple-organ failure after injury. J Trauma Acute Care Surg 74(3):774–779CrossRef
18.
go back to reference Dewar DC, White A, Attia J et al (2014) Comparison of postinjury multiple-organ failure scoring systems: Denver versus Sequential Organ Failure Assessment. J Trauma Acute Care Surg 77:624–629CrossRef Dewar DC, White A, Attia J et al (2014) Comparison of postinjury multiple-organ failure scoring systems: Denver versus Sequential Organ Failure Assessment. J Trauma Acute Care Surg 77:624–629CrossRef
19.
go back to reference Sauaia A, Moore FA, Moore EE (1994) Early predictors of postinjury multiple organ failure. Arch Surg 129:39–45CrossRef Sauaia A, Moore FA, Moore EE (1994) Early predictors of postinjury multiple organ failure. Arch Surg 129:39–45CrossRef
20.
go back to reference Ranieri VM, Rubenfeld GD, Thompson BT, ARDS Definition Task Force et al (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526–2533 Ranieri VM, Rubenfeld GD, Thompson BT, ARDS Definition Task Force et al (2012) Acute respiratory distress syndrome: the Berlin Definition. JAMA 307(23):2526–2533
21.
go back to reference Gunning AC, Leenen LPH (2014) Applicability of the predictors of the historical trauma score in the present Dutch trauma population: modelling the TRISS predictors. J Trauma Acute Care Surg 77:614–619CrossRef Gunning AC, Leenen LPH (2014) Applicability of the predictors of the historical trauma score in the present Dutch trauma population: modelling the TRISS predictors. J Trauma Acute Care Surg 77:614–619CrossRef
22.
go back to reference Van Wessem KJP, Leenen LPH (2018) Reduction in mortality rates of postinjury multiple organ dysfunction syndrome: a shifting paradigm? Prospect Popul-Based Cohort Study Shock 49(1):33–38 Van Wessem KJP, Leenen LPH (2018) Reduction in mortality rates of postinjury multiple organ dysfunction syndrome: a shifting paradigm? Prospect Popul-Based Cohort Study Shock 49(1):33–38
24.
go back to reference Napolitano LM, Cohen MJ, Cotton BA et al (2013) Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg 74(6):1575–1586CrossRef Napolitano LM, Cohen MJ, Cotton BA et al (2013) Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg 74(6):1575–1586CrossRef
26.
go back to reference CRASH-3 Trial Collaborators (2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394:1713–1723CrossRef CRASH-3 Trial Collaborators (2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394:1713–1723CrossRef
27.
go back to reference Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, Bulger EM, Idris AH, Christenson J, Morrison LJ, Frascone RJ, Bosarge PL, Colella MR, Johannigman J, Cotton BA, Callum J, McMullan J, Dries DJ, Tibbs B, Richmond NJ, Weisfeldt ML, Tallon JM, Garrett JS, Zielinski MD, Aufderheide TP, Gandhi RR, Schlamp R, Robinson BRH, Jui J, Klein L, Rizoli S, Gamber M, Fleming M, Hwang J, Vincent LE, Williams C, Hendrickson A, Simonson R, Klotz P, Sopko G, Witham W, Ferrara M, Schreiber MA (2020) Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA 324(10):961–974. https://doi.org/10.1001/jama.2020.8958 (Erratum in: JAMA. 2020 Oct 27;324(16):1683. PMID: 32897344; PMCID: PMC7489866)CrossRefPubMedPubMedCentral Rowell SE, Meier EN, McKnight B, Kannas D, May S, Sheehan K, Bulger EM, Idris AH, Christenson J, Morrison LJ, Frascone RJ, Bosarge PL, Colella MR, Johannigman J, Cotton BA, Callum J, McMullan J, Dries DJ, Tibbs B, Richmond NJ, Weisfeldt ML, Tallon JM, Garrett JS, Zielinski MD, Aufderheide TP, Gandhi RR, Schlamp R, Robinson BRH, Jui J, Klein L, Rizoli S, Gamber M, Fleming M, Hwang J, Vincent LE, Williams C, Hendrickson A, Simonson R, Klotz P, Sopko G, Witham W, Ferrara M, Schreiber MA (2020) Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury. JAMA 324(10):961–974. https://​doi.​org/​10.​1001/​jama.​2020.​8958 (Erratum in: JAMA. 2020 Oct 27;324(16):1683. PMID: 32897344; PMCID: PMC7489866)CrossRefPubMedPubMedCentral
28.
go back to reference Bossers SM, Loer SA, Bloemers FW, Den Hartog D, Van Lieshout EMM, Hoogerwerf N, van der Naalt J, Absalom AR, Peerdeman SM, Schwarte LA, Boer C, Schober P (2020) Association between prehospital tranexamic acid administration and outcomes of severe traumatic brain injury. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.4596 (Epub ahead of print. PMID: 33284310)CrossRef Bossers SM, Loer SA, Bloemers FW, Den Hartog D, Van Lieshout EMM, Hoogerwerf N, van der Naalt J, Absalom AR, Peerdeman SM, Schwarte LA, Boer C, Schober P (2020) Association between prehospital tranexamic acid administration and outcomes of severe traumatic brain injury. JAMA Neurol. https://​doi.​org/​10.​1001/​jamaneurol.​2020.​4596 (Epub ahead of print. PMID: 33284310)CrossRef
Metadata
Title
Does Liberal Prehospital and In-Hospital Tranexamic Acid Influence Outcome in Severely Injured Patients? A Prospective Cohort Study
Authors
Karlijn J. P. van Wessem
Luke P. H. Leenen
Publication date
01-08-2021
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 8/2021
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-021-06143-y

Other articles of this Issue 8/2021

World Journal of Surgery 8/2021 Go to the issue